Skip to main content
BICO Group logo

BICO Group — Investor Relations & Filings

Ticker · BICO ISIN · SE0013647385 LEI · 549300FE4PT8NDXXNK85 ST Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2020-10-22 Interim / Quarterly Rep…
Country SE Sweden
Listing ST BICO

About BICO Group

http://bico.com

BICO Group is a bioconvergence company that provides technologies and solutions for laboratory automation in the life sciences. Integrating biology, engineering, and digital technologies, the company aims to accelerate innovation and automate the lab of the future. BICO offers a portfolio of hardware, software, and services across two business areas: Lab Automation and Life Science Solutions. Its products, including bioprinting technologies, are designed to enhance research efficiency and accuracy for pharmaceutical and biotechnology clients. By automating labor-intensive tasks, the solutions generate standardized, high-quality data, which supports data-driven decision-making and the application of artificial intelligence and machine learning in research and development.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport' (Interim Report) for CELLINK AB, covering the period Jun–Aug 2019/2020 (Q4). It contains detailed financial statements, key performance indicators (EBITDA, net sales, earnings per share), management commentary on business trends, and significant events during the period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q4 2020
2020-10-22 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report' for CELLINK AB, covering the period June–Aug 2019/2020 (Q4). It contains detailed financial statements, key figures, management commentary on performance, and significant events. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q4 2020
2020-10-22 English
Valberedning för CELLINK AB inför årsstämma 2021
Board/Management Information Classification · 1% confidence The document is a press release dated October 20, 2020, announcing the composition of the Nomination Committee (Valberedning) for CELLINK AB's Annual General Meeting (AGM) scheduled for April 26, 2021. It details the members appointed by major shareholders and the chairman. This content directly relates to the preparatory steps and governance structure leading up to the AGM, specifically concerning the nomination of directors and committee members. This falls under the scope of AGM-related materials, but since it is an announcement about the committee composition rather than the meeting presentation itself, it is most closely aligned with general corporate governance or AGM preparation materials. Given the specific options, 'AGM-R' (AGM Information) is the most appropriate fit as it concerns the upcoming Annual General Meeting's preparatory body, the Nomination Committee. It is not a DEF 14A (Remuneration) or CGR (General Governance Report), but a specific announcement related to the AGM process.
2020-10-20 Swedish
Nomination Committee for CELLINK AB in preparation for the 2021 Annual General Meeting
Board/Management Information Classification · 1% confidence The document is a press release dated October 20, 2020, specifically announcing the members appointed to the Nomination Committee in preparation for the upcoming 2021 Annual General Meeting (AGM). It details the composition of the committee and the date of the AGM. This content directly relates to the preparatory and procedural aspects of the Annual General Meeting, fitting the definition of AGM Information (AGM-R). It is not the full AGM presentation itself, but the announcement regarding the committee formation leading up to it, which is closely associated with AGM materials.
2020-10-20 English
Styrelseledamot Artur Aira tillträder som affärsområdeschef för Bioprinting
Board/Management Information Classification · 1% confidence The document is a press release (indicated by "Pressmeddelande") dated October 2, 2020, announcing a significant change in senior management: Artur Aira is leaving the Board of Directors to take on an operational role as Bioprinting Business Area Manager. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-10-02 Swedish
Board Member Artur Aira is taking the position as Bioprinting Business Area Manager
Board/Management Information Classification · 1% confidence The document is a press release announcing a change in senior personnel: a Board Member, Artur Aira, is stepping down from the Board to take on an operational role as Business Area Manager for the bioprinting unit. This directly relates to changes in the company's senior management structure. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document also mentions the need to appoint a new board member in connection with an extraordinary general meeting, further confirming the management/governance context, but the primary focus is the executive appointment.
2020-10-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.